Latin America - Understanding Regulatory Compliance Requirements Across Life Science Industry PART I
Robert J Russell
60 Min
Product Id: 701260
The Latin America Regulatory compliance requirement training/webinar will cover topics relating to pre-clinical and clinical requirements, as well as, addressing the structure of the regulatory agencies in Latin America.
Ensuring the Microbiological Integrity of Pharmaceutical and Biopharmaceutical Facilities
Frank Settineri
90 Min
Product Id: 701145
This Microbiology training/webinar will provide a new approach in ensuring the Microbiological Integrity of Pharmaceutical and Biopharmaceutical Facilities.
Japanese PAL - JPAL QMS requirements in Ordinance 169 and differences to ISO 13485
Phil Smart
90 Min
Product Id: 701290
This JPAL (Japanese Pharmaceutical Affairs Law) QMS training/webinar will explore, in detail, the QMS requirements placed on the foreign manufacturer via Ministerial Ordinance 169, Ordinance 2 and Ordinance 179.
Water System Compliance - Harmonizing Water Microbial Testing for Optimal Quality Control
T.C Soli
90 Min
Product Id: 701300
This water compliance training/webinar covers the reasons for diverse types of flora from one type of water to the next, the differences in the compendial water test methods, the advantages and disadvantages of harmonization.
Japan - Regulatory Filing Requirements and Compliance Processes for Life Sciences PART II
Robert J Russell
90 Min
Product Id: 701266
This Japan Regulatory Filing training for life sciences is designed to provide an overview of the regulatory environment in Japan.
Good Laboratory Practices (GLP): Documenting Deviations & Unexpected Circumstances
Celeste Rose
60 Min
Product Id: 701246
This Good Laboratory Practice training defines deviations and unexpected events, the similarities and differences between deviations and amendments, and will present strategies to minimize the occurrence of unnecessary deviations.
Control Activities Component of COSO at the Entity Level
John C Blackshire
90 Min
Product Id: 700974
This COSO training will provide an in depth look at the Control Activities Component of COSO at the Entity Level. The goals of these principles within this Component are to allow for the Key Controls at various layers and levels within ICFR to reduce risks of achievement of financial reporting objectives.
Use of Spreadsheets to Report Data in FDA Regulated Industries
Robert Ferer
60 Min
Product Id: 701298
This Spreadsheet validation training will cover the use of spreadsheets to report data from the inception of the spreadsheet (user requirement specification), through the development process, validation, and use.
Japanese PAL - Dealing with a JPAL Quality Interface Agreement between the foreign manufacturer and MAH (Marketing Authorization Holder)
Phil Smart
90 Min
Product Id: 701277
This JPAL training will describe requirements, common mistakes & best practices while dealing with a JPAL Quality Interface Agreement between the foreign manufacturer and MAH (Marketing Authorization Holder).
Water System Compliance - What Makes Water Systems Have Microbial Quality Problems
T.C Soli
90 Min
Product Id: 701283
This Water System Compliance training will review what biofilm is and how it grows and will cover how it affects just about every kind of unit operation used in today's water systems.
How to Implement Risk Management Principles and Activities within a Quality Management System
Thomas Gray
60 Min
Product Id: 701224
This Quality management training will guide you Implement Risk Management Principles and Activities within a Quality Management System & ISO-based Quality Management System Reviews.
Japan - Regulatory Filing Requirements and Compliance Processes for Life Sciences PART I
Robert J Russell
90 Min
Product Id: 701258
This Regulatory compliance training is designed to provide an overview of the regulatory environment in Japan.
New Medical Device Vigilance Guidelines
David Dills
60 Min
Product Id: 701140
This Medical device training will provide valuable assistance and guidance to all medical device companies and user facilities involved in medical device vigilance. A revised medical device guidance document on post marketing vigilance (MEDDEV 2.12-1 rev 5) was published in April 2007 by the European Commission and came into force on January 1, 2008. The 2007 update provides more guidance than the previous version, introduced in 2001, and includes new reporting terminology and concepts such as periodic summary reporting and trend reporting. In addition, the terms advisory notice, near incident, and recall have been eliminated or replaced.
The vigilance guidelines are part of a set of European medical device guidelines, known as MEDDEV documents, which are intended to promote a common approach by all involved parties on interpreting and complying with the Medical Device Directive. MEDDEV includes new reporting terminology and concepts such as “periodic summary reporting” and “trend reporting.” In addition, the timescale for reporting incidents is stricter. The terms “advisory notice,” “near incident” and “recall” have been eliminated or replaced by the new terms. As with the 2001 version, the new version refers to the incorporation of the views of the Global Harmonization Task Force (GHTF) into the European context.
How to Prepare for, Manage, and Follow-up to an FDA Inspection
Jeff Kasoff
60 Min
Product Id: 701236
This FDA inspection training will discuss how to prepare for the inspection, what to do during the inspection and the close-out interview, and how to respond to the inspection.
Japanese PAL - Navigating the Japanese Pharmaceutical Affairs Law
Phil Smart
90 Min
Product Id: 701276
This JPAL training will emphasize on Japanese Pharmaceutical Affairs law with respect to - Classification, device approvals, clinical data, MAH (Marketing Authorization Holder),foreign manufacturer accreditation,QMS,post-market complaints & vigilance
Maintaining a Sustainable and Compliant Design Validation System and Using FMEA for Device Manufacturers
David Dills
60 Min
Product Id: 701074
This webinar will provide valuable assistance and guidance for medical device companies to ensure they have a well defined, deployed and enforceable design validation program. Did I make the right product and can I prove it is Design Validation! Device manufacturers need to establish and maintain procedures for validating the device design. Design validation has to be performed under defined operating conditions on initial production units, lots, or batches, or their equivalents. Design validation must ensure that the company’s device or devices conform to defined user needs and intended uses and will include testing of production units under actual or simulated use conditions.
Auditing and Compliance of Biopharmaceutical API Facilities
Frank Settineri
90 Min
Product Id: 701208
This FDA audit training will review the fundamental aspects of auditing biopharmaceutical API facilities to ensure their compliance with current regulatory guidelines.
HACCP in a Real World Environment
John Miller
60 Min
Product Id: 701173
This HACCP training will explain the FSIS regulations and policies program requirements.
The EU Clinical Trial Directive
Robert J Russell
90 Min
Product Id: 701259
This Clinical trial training will focus on understanding the requirements of the new EU Clinical Trial Directive and the issues inherent in any new regulatory process.
Risk Management as applied to Design Control
Nicolaas Besseling
60 Min
Product Id: 701212
This Risk management training will guide you through how to integrate the elements of ISO14971 (Risk management for medical devices) in your design process.